Amkor (AMKR) stock price slides into earnings week — what to watch before Monday’s open

Amkor (AMKR) stock price slides into earnings week — what to watch before Monday’s open

New York, Feb 1, 2026, 20:54 ET — The market has closed.

  • AMKR ended Friday down 3.3% at $48.33, slipping after a 6.7% intraday swing.
  • Chip stocks took a broad hit heading into the weekend, leaving packaging names unsettled.
  • Amkor is set to release its quarterly earnings on Feb. 9, providing a key near-term catalyst for the stock’s direction.

Amkor Technology, Inc. shares fell 3.3% on Friday, closing at $48.33. The stock swung between $47.79 and $50.99 during the session, with roughly 3.38 million shares changing hands, according to market data. (Investing)

Timing is key. The chip-packaging company will release its Q4 and full-year 2025 earnings after the market closes on Feb. 9, with a conference call scheduled for 5 p.m. Eastern. Traders will be positioning ahead of the week, watching closely for guidance and demand cues. (Business Wire)

Friday’s drop came as the broader U.S. market grew wary over interest rate and policy prospects. “Markets are calibrating to Trump’s pick of Kevin Warsh,” said Michael Hans, chief investment officer at Citizens Wealth. Angelo Kourkafas, senior global strategist at Edward Jones, cited “a combination of investor concerns” tied to the Fed chair announcement, mixed tech earnings, and inflation pressures. (Reuters)

Semiconductors bore a sharp blow. The Philadelphia semiconductor index dropped roughly 3.9% on Friday, according to St. Louis Fed data, highlighting the sector’s swift shift in sentiment. (FRED)

Earnings reports pile up this week, with potential ripple effects across chip supply chains — including firms outside chip design. Advanced Micro Devices is set to report Tuesday, Alphabet follows on Wednesday, and Amazon.com alongside Qualcomm close out the week. (Kiplinger)

Amkor operates as an OSAT, or outsourced semiconductor assembly and test provider, handling chip packaging and final testing before devices reach customers. Investors will focus on any updates about advanced packaging, a technique that enhances chip integration for better performance, as well as whether demand remains stable across sectors like smartphones, data centers, and automotive.

Analysts have kept a close watch on the stock lately. On Jan. 5, Charles Shi of Needham & Company held firm on a “Buy” rating and boosted his price target to $50, per a GuruFocus roundup of recent analyst moves. (GuruFocus)

The stock’s direction now hinges on the company’s comments about orders and pricing, not just the raw figures. A cautious outlook on customer demand or margins could weigh on shares, especially if chip-sector volatility continues.

Traders are set to eye follow-through once U.S. markets open Monday, before turning their attention sharply to Feb. 9 — when AMKR reports earnings after the close, followed by a 5 p.m. Eastern call — marking the next key catalyst.

Stock Market Today

  • Profound Medical: Top TSX Growth Stock Poised for Rapid Expansion, Q3 Revenues Surge 87%
    February 1, 2026, 9:22 PM EST. Profound Medical (TSX:PRN), a Canadian medical device firm specializing in MRI-guided ultrasound therapies, is highlighted as the sole TSX growth stock to hold for the next three years. The company reported an 87% revenue increase in Q3 to $5.3 million, driven by expanded installations of its flagship TULSA-PRO prostate cancer treatment system. Offering incision-free, MRI-guided ablation technology, Profound's procedures have gained Medicare approval with rising insurance reimbursements. Despite a net loss of $8 million, the company improved gross margins to 74.3% and ended Q3 with $25 million cash, supporting near-term liquidity. With 70 systems installed and 93 in advanced sales stages, Profound aims for 75 installations by year-end, making it a notable small-cap growth stock in healthcare on the TSX.
JCET Group Class A shares slide in early Shanghai trade — what could move 600584 next
Previous Story

JCET Group Class A shares slide in early Shanghai trade — what could move 600584 next

Go toTop